Susquehanna International Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $900K | Buy |
328,400
+149,200
| +83% | +$472K | ﹤0.01% | 8161 |
|
|
2025
Q4 | $663K | Sell |
179,200
-106,300
| -37% | -$343K | ﹤0.01% | 8154 |
|
|
2025
Q3 | $757K | Buy |
285,500
+56,500
| +25% | +$109K | ﹤0.01% | 8003 |
|
|
2025
Q2 | $224K | Sell |
229,000
-53,100
| -19% | -$53.2K | ﹤0.01% | 10969 |
|
|
2025
Q1 | $406K | Sell |
282,100
-201,600
| -42% | -$371K | ﹤0.01% | 9362 |
|
|
2024
Q4 | $1.06M | Buy |
483,700
+52,500
| +12% | +$122K | ﹤0.01% | 6794 |
|
|
2024
Q3 | $711K | Sell |
431,200
-74,700
| -15% | -$151K | ﹤0.01% | 7606 |
|
|
2024
Q2 | $1.12M | Buy |
505,900
+96,800
| +24% | +$228K | ﹤0.01% | 6315 |
|
|
2024
Q1 | $1.1M | Buy |
409,100
+105,200
| +35% | +$256K | ﹤0.01% | 6671 |
|
|
2023
Q4 | $909K | Buy |
303,900
+189,800
| +166% | +$246K | ﹤0.01% | 7215 |
|
|
2023
Q3 | $112K | Buy |
114,100
+17,900
| +19% | +$25.9K | ﹤0.01% | 10826 |
|
|
2023
Q2 | $134K | Sell |
96,200
-18,100
| -16% | -$25.3K | ﹤0.01% | 10688 |
|
|
2023
Q1 | $182K | Sell |
114,300
-542,200
| -83% | -$2.8M | ﹤0.01% | 10711 |
|
|
2022
Q4 | $4.09M | Buy |
656,500
+453,000
| +223% | +$3.24M | ﹤0.01% | 3541 |
|
|
2022
Q3 | $1.36M | Buy |
203,500
+137,700
| +209% | +$946K | ﹤0.01% | 5828 |
|
|
2022
Q2 | $418K | Sell |
65,800
-52,000
| -44% | -$295K | ﹤0.01% | 8713 |
|
|
2022
Q1 | $547K | Buy |
117,800
+33,900
| +40% | +$145K | ﹤0.01% | 8747 |
|
|
2021
Q4 | $420K | Sell |
83,900
-65,700
| -44% | -$526K | ﹤0.01% | 9636 |
|
|
2021
Q3 | $1.8M | Sell |
149,600
-31,800
| -18% | -$463K | ﹤0.01% | 6064 |
|
|
2021
Q2 | $3.84M | Sell |
181,400
-17,100
| -9% | -$412K | ﹤0.01% | 4523 |
|
|
2021
Q1 | $5.57M | Sell |
198,500
-64,500
| -25% | -$1.9M | ﹤0.01% | 3699 |
|
|
2020
Q4 | $6.84M | Buy |
263,000
+145,800
| +124% | +$4.37M | ﹤0.01% | 2976 |
|
|
2020
Q3 | $4.36M | Buy |
117,200
+13,600
| +13% | +$539K | ﹤0.01% | 3243 |
|
|
2020
Q2 | $5.32M | Sell |
103,600
-84,800
| -45% | -$3.55M | ﹤0.01% | 2922 |
|
|
2020
Q1 | $5.94M | Buy |
188,400
+47,900
| +34% | +$2.53M | ﹤0.01% | 2356 |
|
|
2019
Q4 | $8.38M | Sell |
140,500
-42,100
| -23% | -$1.89M | ﹤0.01% | 2288 |
|
|
2019
Q3 | $6.69M | Sell |
182,600
-500
| -0.3% | -$19.8K | ﹤0.01% | 2376 |
|
|
2019
Q2 | $8.52M | Sell |
183,100
-134,800
| -42% | -$6.33M | ﹤0.01% | 2055 |
|
|
2019
Q1 | $12.8M | Buy |
317,900
+82,800
| +35% | +$3.71M | 0.01% | 1528 |
|
|
2018
Q4 | $10.8M | Sell |
235,100
-438,600
| -65% | -$21.1M | ﹤0.01% | 1543 |
|
|
2018
Q3 | $29.9M | Sell |
673,700
-139,800
| -17% | -$6.42M | 0.01% | 1022 |
|
|
2018
Q2 | $31.9M | Buy |
813,500
+298,200
| +58% | +$15.1M | 0.01% | 946 |
|
|
2018
Q1 | $37.3M | Buy |
515,300
+335,400
| +186% | +$24.6M | 0.01% | 807 |
|
|
2017
Q4 | $11.8M | Buy |
179,900
+105,700
| +142% | +$5.69M | ﹤0.01% | 1693 |
|
|
2017
Q3 | $3.72M | Sell |
74,200
-176,900
| -70% | -$8.53M | ﹤0.01% | 2917 |
|
|
2017
Q2 | $11.6M | Sell |
251,100
-128,400
| -34% | -$4.72M | 0.01% | 1583 |
|
|
2017
Q1 | $13.4M | Buy |
379,500
+355,600
| +1,488% | +$8.14M | 0.01% | 1368 |
|
|
2016
Q4 | $299K | Sell |
23,900
-53,200
| -69% | -$633K | ﹤0.01% | 7977 |
|
|
2016
Q3 | $1.07M | Sell |
77,100
-50,900
| -40% | -$577K | ﹤0.01% | 4684 |
|
|
2016
Q2 | $1.26M | Buy |
128,000
+55,500
| +77% | +$920K | ﹤0.01% | 4379 |
|
|
2016
Q1 | $1.23M | Sell |
72,500
-21,500
| -23% | -$346K | ﹤0.01% | 4674 |
|
|
2015
Q4 | $2.09M | Sell |
94,000
-276,000
| -75% | -$6.96M | ﹤0.01% | 3943 |
|
|
2015
Q3 | $8.73M | Sell |
370,000
-7,100
| -2% | -$446K | ﹤0.01% | 1987 |
|
|
2015
Q2 | $30.8M | Buy |
377,100
+44,500
| +13% | +$4.36M | 0.01% | 977 |
|
|
2015
Q1 | $30.8M | Buy |
332,600
+319,400
| +2,420% | +$20.6M | 0.01% | 914 |
|
|
2014
Q4 | $534K | Buy |
+13,200
| New | +$404K | ﹤0.01% | 7090 |
|
Other funds holding ESPR
WA
TSC
O
VCM
